Abstract
There are many similarities in molecular mechanisms of neuronal cell death observed in ischemic stroke and Alzheimers disease. From point of organelle damage, we introduced molecular events seen in ischemic stroke, and compared the findings with that observed in Alzheimers disease. In the brain after ischemia, transmembrane potential and ion gradient are disturbed at very early stage. Several drugs are aimed to minimize this change, some of which were effective in experimental models. Calcium blocker and glutamate antagonist were also effective for Alzheimers disease. As for mitochondrial and endoplasmic reticulum damage, both disorders share common pathological findings such as proapoptotic signals activation. However, there are some molecules which are neuroprotective in Alzheimers disease but pro-apoptotic in ischemic neurons. We need to be so careful for judging the significance of a phenomenon obtained by an experiment. Lysosome, called as suicide bag, play important roles both in the brain of ischemic stroke and Alzheimers disease. Leak of lysosomal enzymes influence, at least partially, the fate of neurons under pathological conditions in both disorders.
Keywords: Alzheimer's disease, cell death, ischemia, organelle
Current Alzheimer Research
Title: Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease
Volume: 3 Issue: 4
Author(s): Takeshi Hayashi, Mikio Shoji and Koji Abe
Affiliation:
Keywords: Alzheimer's disease, cell death, ischemia, organelle
Abstract: There are many similarities in molecular mechanisms of neuronal cell death observed in ischemic stroke and Alzheimers disease. From point of organelle damage, we introduced molecular events seen in ischemic stroke, and compared the findings with that observed in Alzheimers disease. In the brain after ischemia, transmembrane potential and ion gradient are disturbed at very early stage. Several drugs are aimed to minimize this change, some of which were effective in experimental models. Calcium blocker and glutamate antagonist were also effective for Alzheimers disease. As for mitochondrial and endoplasmic reticulum damage, both disorders share common pathological findings such as proapoptotic signals activation. However, there are some molecules which are neuroprotective in Alzheimers disease but pro-apoptotic in ischemic neurons. We need to be so careful for judging the significance of a phenomenon obtained by an experiment. Lysosome, called as suicide bag, play important roles both in the brain of ischemic stroke and Alzheimers disease. Leak of lysosomal enzymes influence, at least partially, the fate of neurons under pathological conditions in both disorders.
Export Options
About this article
Cite this article as:
Hayashi Takeshi, Shoji Mikio and Abe Koji, Molecular Mechanisms of Ischemic Neuronal Cell Death - With Relevance to Alzheimers Disease, Current Alzheimer Research 2006; 3 (4) . https://dx.doi.org/10.2174/156720506778249498
DOI https://dx.doi.org/10.2174/156720506778249498 |
Print ISSN 1567-2050 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5828 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Meet Our Editorial Board Member
CNS & Neurological Disorders - Drug Targets The Honolulu-Asia Aging Study: Epidemiologic and Neuropathologic Research on Cognitive Impairment
Current Alzheimer Research Synthesis, Antioxidant and Anti-inflammatoy Effects of Antioxidant Acid Amides with GABA and N-Acyl-pyrrolidin-2-ones
Current Chemical Biology EDITORIAL: Neuroprotection Mechanisms and their Potential Applications
Current Neuropharmacology Effect of Synthetic Cannabinoid HU210 on Memory Deficits and Neuropathology in Alzheimers Disease Mouse Model
Current Alzheimer Research Clinical Uses of Melatonin: Evaluation of Human Trials
Current Medicinal Chemistry Redox Chemistry of Green Tea Polyphenols: Therapeutic Benefits in Neurodegenerative Diseases
Mini-Reviews in Medicinal Chemistry COPD Evaluation: Beyond the Airway Obstruction, a Follow Up
Current Respiratory Medicine Reviews Purines and Pyrimidines: Metabolism, Function and Potential as Therapeutic Options in Neurodegenerative Diseases
Current Protein & Peptide Science Treatment of Anderson-Fabry Disease
Current Pharmaceutical Design New Technologies for Drug Delivery Across the Blood Brain Barrier
Current Pharmaceutical Design Editorial: Early Recognition of Dementia in Primary Care- Current Issues and Concepts
Current Alzheimer Research Chondroitin Sulfate Glycosaminoglycans for CNS Homeostasis-Implications for Material Design
Current Medicinal Chemistry Maternal Fish Oil Supplementation: The Prodrom of Synaptic Protection in Alzheimers Disease
Current Nutrition & Food Science Pharmacological Inhibitors of NAD Biosynthesis as Potential An ticancer Agents
Recent Patents on Anti-Cancer Drug Discovery Visuospatial Memory in Healthy Elderly, AD and MCI: A Review
Current Aging Science Kallikrein-Kinin System Mediated Inflammation in Alzheimers Disease In Vivo
Current Alzheimer Research Radiosyntheses using Fluorine-18: The Art and Science of Late Stage Fluorination
Current Topics in Medicinal Chemistry The Safety, Tolerability, Pharmacokinetics and Cognitive Effects of GSK239512, a Selective Histamine H<sub>3</sub> Receptor Antagonist in Patients with Mild to Moderate Alzheimer’s Disease: A Preliminary Investigation
Current Alzheimer Research 4-Hydroxynonenal in the Pathogenesis and Progression of Human Diseases
Current Medicinal Chemistry